Hugo Cedrón

1/9 The 2026 ACC/AHA Dyslipidemia Guidelines are officially here! Replacing the 2018 guidelines, these new updates bring major shifts in risk assessment, novel lipid markers, and cholesterol targets. Here are the most salient features you need to know. 🧵👇 #Cardiology #MedTwitter

🩺 Gastric ulcer follow-up: is routine “relook” endoscopy always justified? BSG guidance recommends repeat OGD at 6–8 weeks for all gastric ulcers ⏳🔁—but service pressure is real 🏥📉 This review (19 studies + 6 abstracts) finds: 🔎 Cancer at follow-up is very low and often already suspected at index even with negative histology 🧷 Emphasises careful endoscopic assessment + adequate biopsies (≥6 from edge + base) 🧫✅ Read: doi.org/10.1136/flgast… #UpperGI #Endoscopy #GastricCancer #QualityImprovement @PhilSmithIsBack @OTavabie @dr_aditi_kumar @TrevorTabone @eathar_s @IrenePerezMD @KGananandan @zare_benjamin @medicalreg @dtleiberman @BASLedu @BSGtrainees @WorldGastroOrg @ulstergastro @SEEDendoscopia @EASLedu @AmCollegeGastro @Aegastro @SAGES_updates @UHSEndoscopy @WAGE_media @my_UEG @amergastroassn @NASPGHAN @ESGE_news

In this months #FG: ⏳🍺 The first three months after admission with decompensated alcohol related cirrhosis are critical, and outcomes are often poor. In this prospective regional study, mortality at 3 months was 24%, relapse to alcohol was common, and fewer than half of patients engaged with alcohol services after discharge. 📊 Despite clear transplant indications in many, ongoing alcohol use remained a major barrier to transplant eligibility, highlighting the urgent need for better integrated hepatology and addiction care during this high risk period. fg.bmj.com/content/17/1/58 @PhilSmithIsBack @OTavabie @dr_aditi_kumar @TrevorTabone @eathar_s @IrenePerezMD @KGananandan @zare_benjamin @medicalreg @dtleiberman @BASLedu @IQILS_Liver @LiverTrust @BSGTrainees @BritSocGastro @EASLnews @EASLedu @NHSBT @CKOWork 

IBD care in Spain has a national benchmark: @geteccu As the reference in IBD, GETECCU has built a structured model of quality standards, certified IBD units, research &national coordination that has gone beyond borders Through the ENEIDA registry (now including >85,000patients from over 100 centres) Spain has developed one of the largest real-world IBD datasets worldwide, enabling high-impact multicentre research pmc.ncbi.nlm.nih.gov/articles/PMC12… This article outlines how vision, structure and long-term commitment can transform IBD care Congrats @yzabanaa @anaguticasbas @manu_barreiro @pilarnos @jp_gisbert @IBDcanruti @fgomollon

Con mis grandes amigos en ECCO 2026, Stockholm!

We are excited to discuss @YOGI_IBD for the first time at #ECCO2026 Stockholm. Bringing young minds to discuss global IBD educational needs. Thank you @sanofi for support Join us at youngibd.org @ign76 @KaazanPatricia @Bealoquebea @drvishal82 @ibdseb

Epicom - Reality in LATAM @pancco_org

IBD Journal Scan 📚 New nationwide data (>54,000 pts) in Clinical Gastroenterology & Hepatology (Feb 2026) shows: No dysplasia → ~2.3% progression Indefinite → ~5.3% Low-grade → ~8.3% High-grade → ~40% CRC (often within 1 year) Dysplasia grade = risk signal. Personalized surveillance prevents advanced CRN. DOI: 10.1016/j.cgh.2026.01.043 Great work by @DrJordanAxelrad @AdamFayeMD and the team linkedin.com/posts/ibd-libr…

Enjoy!!! #v=onepage&q&f=false" target="_blank" rel="nofollow noopener">books.google.com.pe/books?id=ZVO0D…

@manu_barreiro present at #ECCO2026 @IriaBaston @Rocio_stg @GastroCHUSv2

A classic often forgotten 👇👇👇👇👇👇👇👇

@ign76 @IBDJournals @DCharabaty @CrohnsColitisFn @Y_ECCO_IBD @YOGI_IBD @my_ueg @Bealoquebea @JosephHabibi_MD @fgomollon @ibdseb @geteccu @sepdigestiva @drvishal82 @pancco_org @JeanFredericCo1 @IBDimmunology Congratulations Nacho!!

🟣 Very happy to share that I am starting as Associate Editor for CC360 @IBDJournals !!! Truly an honour to join such an oustanding team! Thanks to @DCharabaty Editor in Chief and @CrohnsColitisFn for the invitation 🙌 @Y_ECCO_IBD @YOGI_IBD @my_ueg

Nueva guía multidisciplinar sobre EHmet: detección precoz, uso de pruebas no invasivas (FIB-4, NFS, HFS), dieta mediterránea, ejercicio y nuevos fármacos como resmetirom y semaglutida. Clave: manejo coordinado entre especialidades para frenar progresión y mejorar supervivencia.

💡🆕 Evaluación no invasiva de la fibrosis hepática Revisión en @NEJM Incluye: 1️⃣ Algoritmo de abordaje 2️⃣ Diagnóstico y estadificación de la fibrosis hepática 3️⃣ Resumen de las pruebas no invasivas 📸: nejm.org/doi/full/10.10…

Can spleen stiffness measurement help to detect portal hypertension? A very important paper just published in @LancetGastroHep shows that, in combination with liver stiffness, platelets & BMI, it predicts the presence of clinically significant portal hypertension. PMID: 39326431

Copa América PANCCO 2026 @pancco_org

@puentesfabi @Y_ECCO_IBD

Any tip about weather in 🇸🇪? ⁦@Y_ECCO_IBD⁩

🎊 La @revgastroperu y su Comité Editor les desean un muy Feliz Año Nuevo 2026 🎆🥂 📢 Ya está disponible nuestro último número N4-2025, y un enfoque especial en Neurogastroenterología 🧠🩺 🔗 Link: revistagastroperu.com/index.php/rgp/… 👉 ¡Los invitamos a revisarlo, leerlo y compartirlo! 📖✨

Classification of Paraesophageal or Hiatal Hernias, With An Example